1Cabezudo M,O labe J,Bacci F.Infection of intervenebral displace after placement of percutaneous lumboperitoneal for benig intracranial hypertention[J].Neurosurgery,1990,26(6):1005-1009.
1Cabezudo JM,Olabe J.Bacci F.Infection of intervenebral displace after placement of percutaneous lumboperitoneal for benign intracranial hypertention.Neurosurgery,1990,26(6):1005-1009.
2Kestle J,Drake J,Milner R,et al.Long-term follow-up data from the Shunt Design Trial.Ped Neurosurg,2000,33(5):230-236.
3Chernov MF,Kamikawa S,Yamane F,et al.Neurofiberscope-guided management of slit-ventricle syndrome due shunt placement.J Neurosurg-(Pediatrics3),2005,102 (3 suppl):260-267.
4Del Bigio MR.Biological reactions to cerebrospinal fluid shunt devices:a review of cellular pathology.Neurosurgery,1998,42(2):319-326.
5Arnell K,Olsen L.Distal catheter obstruction from non-infention 2 cause in ventriculo peritoneal shunted children.J Pediatr surg,2004.14(4):245-349.
6Browd SR,Ragel BT,Gottfried ON,et al.Failure of cerebrospinal fluid shunts part Ⅰ:obstruction and mechanical failure.Pediatric Neurosurgery,2006,34(2):83 -92.
7Rayport M,Resiss J.Hydrodynamic properties of certain shunt assemblies for the treatment of hydrocephalus.J Neurosurg,1969,30(4):455-467.
8Brydon HL,Huyward R,Harkness W.Physical properties of cerebrospinal fluid of relevance to shunt function 1:the effect of protein up on CSF viscosity.J Neurosurg,1995,9 (5):639-644.
9Baird C,Farner S,Mohr C,et al.The Effects of Protein,Red Blood Cells and Whole Blood on PS Valve Function.Pediatric Neurosurg,2002,37(4):186-193.
10Schuhmann MU,Ostrowski KR,Draper EJ,et al.The value of C-reactive protein in the management of shunt Infections.J Neurosurg (Pediatrics3)2005,103(3 Suppl):223 -230.
